Reduced oxidative stress in parallel to improved cardiac performance one year after selective removal of anti-beta 1-adrenoreceptor autoantibodies in patients with idiopathic dilated cardiomyopathy: Data of a preliminary study

Journal of Clinical Apheresis

Volumn 20, Issue 3, 2005, Pages 137-142

  Schimke, Ingolf ^a,f   Müller, Johannes ^b   Dandel, Michael ^b   Gremmels, Heinz Detlef ^c   Bayer, Wolfgang ^d   Wallukat, Barbara ^b   Wallukat, Gerd ^e   Hetzer, Roland ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c Veterinärmedizinisch Diagnostisches Institut Berlin   (Germany)

^d Labor für Spektralanalytische und Biologische Untersuchungen Stuttgart   (Germany)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adrenoreceptor autoantibodies; Dilated cardiomyopathy; Immunoadsorption; Lipid peroxides; Oxidative stress

Indexed keywords

ATORVASTATIN; AUTOANTIBODY; BETA 1 ADRENERGIC RECEPTOR; CARVEDILOL; IMMUNOGLOBULIN G; LIPID PEROXIDE; METOPROLOL; RECEPTOR ANTIBODY; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONGESTIVE CARDIOMYOPATHY; CORRELATION ANALYSIS; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART PERFORMANCE; HEART VENTRICLE WALL MOTION; HUMAN; IMMUNOADSORPTION; LIPID PEROXIDATION; MALE; OPEN STUDY; OXIDATIVE STRESS; PILOT STUDY; WILCOXON SIGNED RANKS TEST;

ADSORPTION; ADULT; AUTOANTIBODIES; CARDIOMYOPATHY, DILATED; FEMALE; HEMODIAFILTRATION; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PILOT PROJECTS; RECEPTORS, ADRENERGIC, BETA-1; RECOVERY OF FUNCTION; VENTRICULAR FUNCTION, LEFT;

EID: 30544443442     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20050     Document Type: Article

References (30)

1. Magnusson Y, Wallukat G, Waagstein F, Hjalmarson A, Hoebeke J. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoreceptor with positive chronotropic effect. Circulation 1994;89:2760-2767.
2. Matsui S, Fu ML, Katsuda S, Hayase M, Yamaguchi N, Kurihara T, Takekoshi N, Murakami E, Hoebeke J, Hjalmeason A. Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol 1997;29:641-655
3. Iwata M, Yoshikawa T, Baba A, Anzai T, Nakamura I, Wainai Y, Takahashi T, Ogawa S. Autoimmunity against the second extracellular loop of beta 1-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo. Circ Res 2001;88:578-586.
4. Wallukat G, Nissen E, Morwinski R, Muller J. Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy. Herz 2000;25:261-266.
5. Mak S, Newton GE. The oxidative stress hypothesis of congestive heart failure: radical thoughts. Chest 2001;120:2035-2046.
6. Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 2002;34:379-388.
7. Muller J, Wallukat G, Dandel M, Bieda H, Brandes K, Spiegelsberger S, Nissen E, Kunze R, Hetzer R. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation. 2000;101:385-391.
8. Schimke I, Muller J, Priem F, Kruse I, Schon B, Stein J, Kunze R, Wallukat G, Hetzer R. Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption. J Am Coll Cardiol 2001;38:178-183.
9. Wallukat G, Muller J, Hetzer R. Specific removal of beta 1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy. N Engl J Med 347:221806.
10. Rönspeck W, Brinckmann R, Egner R, Gebauer F, Winkler D, Jekow P, Wallukat G, Müller J, Kunze R. Peptide based adsorbers for therapeutic immunoadsorption. Ther Apher Dial. 2003;7:91-97.
11. Wallukat G, Wollenberger A, Morwinski R, Pitschner HF. Anti-beta 1-adrenoreceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol 1995;27:397-406.
12. Erratum in: J Mol Cell Cardiol 1995;9527:2529.
13. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davidson TW, Davis JL, Douglas PS, Gillam LD. ACC/AHA Guidelines for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practical Guidelines (Committee on Clinical Application of Echocardiography) developed in collaboration with the American Society of Echocardiography. Circulation 1997;95:1686-1744.
14. Dandel M, Hummel M, Muller J, Wellnhofer E, Meyer R, Solowjowa N, Ewert R, Hetzer R. Reliability of tissue Doppler wall motion monitoring after heart transplantation for replacement of invasive routine screenings by optimally timed cardiac biopsies and catheterizations. Circulation 2001;104(12Suppl 1):184-191.
15. Sutherland GR, Stewart MJ, Groundstroem KW. Color Doppler myocardial imaging: a new technique for the assessment of myocardial function. J Am Soc Echocardiogr 1994;7:441-458.
16. Dandel M, Wellnhofer E, Hummel M. Early detection of left ventricular dysfunction related to transplant coronary artery disease. J Heart Lung Transplant 2003;22:1353-1364.
17. McMurray J, McLay J, Chopra M, Bridges A, Belch JJ. Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 19901565:1261-1262.
18. Belch JJ, Bridges AB, Scott N, Chopra M. Oxygen free radicals and congestive heart failure. Br Heart J 1991;65:245-248.
19. Diaz-Velez CR, Garcia-Castineiras S, Mendoza-Ramos E, Hernandez-Lopez E. Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am Heart J 1996;131:146-152.
20. Keith M, Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS, Jeejeebhoy KN. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 1998;31:1352-1356.
21. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990;9:515-540.
22. Kukin ML, Kalman J, Charney RH, Levy DK, Buchholz-Varley C, Ocampo ON, Eng C. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure. Circulation 1999;99:2645-2651.
23. Ruffolo RR Jr, Feuerstein GZ. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure. Cardiovasc Drugs Ther 1997;11(Suppl 1):247-256.
24. Liao JK. Statin therapy for cardiac hypertrophy and heart failure. J Invest Med. 2004;52:248-253.
25. Sawyer DB, Colucci WS. Mitochondrial oxidative stress in heart failure "oxygen wastage" revisited. Circ Res 2000;86:119-120.
26. Bristow MR. Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol 1997;80:26L-40L.
27. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P. Strech-induced programmed myocyte cell death. J Clin Invest 1995;96:2247-2259.
28. Kakishita M, Nakamura K, Asanuma M. Direct evidence for increased hydroxyl radicals in angiotensin II-induced cardiac hypertrophy through angiotensin II type 1a receptor. J Cardiovasc Pharmacol 2003;42(Suppl 1):S67-70.
29. Li X, Moody MR, Engel D, Walker S, Clubb FJ, Sivasubramanian N, Mann DL, Reid MB. Cardiac-specific overexpression of tumor necrosis factor-α causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation 2000;102:1690-1696.
30. Ferdynandy P, Danial H, Ambrus I, Rothery RA, Schulz R. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 2000;87:170-172.